2-(Chloromethyl)-4,5-difluoro-1H-benzo[d]imidazole

Catalog No. :
ACRHNO342
CAS No. :
1111269-40-9
Molecular Formula :
C8H5ClF2N2
Molecular Weight :
202.59

IUPAC Name:2-(chloromethyl)-4,5-difluoro-1H-benzo[d]imidazole

2-(Chloromethyl)-4,5-difluoro-1H-benzo[d]imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$145.00Login to see priceIn stockInquiry
250mg95%$245.00Login to see priceIn stockInquiry
1g95%$537.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Chloromethyl)-4,5-difluoro-1H-benzo[d]imidazole
IUPAC Name2-(chloromethyl)-4,5-difluoro-1H-benzo[d]imidazole
MDL No.MFCD24465125
Molecular FormulaC8H5ClF2N2
Molecular Weight202.59
SMILESFC1=CC=C2NC(CCl)=NC2=C1F
InChI KeyCOFYXFSSDRHBSB-UHFFFAOYSA-N
Synonym2-(Chloromethyl)-4,5-difluoro-1H-benzimidazole;2-(Chloromethyl)-4,5-difluoro-1H-benzo[d]imidazole;2-(chloromethyl)-6,7-difluoro-1H-Benzimidazole;1H-Benzimidazole, 2-(chloromethyl)-6,7-difluoro-
CAS No.1111269-40-9
PubChem CID59503811

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACRHNO342 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRSTD286 route compound structure diagram
    ACRSTD286153505-39-6 In Stock
  2. Then
  3. ACRHNO342 route product structure diagram
    ACRHNO3421111269-40-9 In Stock
Inquiry

2. ACRHNO342 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRSTD286 route compound structure diagram
    ACRSTD286153505-39-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRHNO342 route product structure diagram
    ACRHNO3421111269-40-9 In Stock
Inquiry

Comments (0)